Back to Search
Start Over
A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi.
- Source :
-
FEBS letters [FEBS Lett] 1997 Jan 20; Vol. 401 (2-3), pp. 259-61. - Publication Year :
- 1997
-
Abstract
- A peptide fragment derived from the p41 form of the invariant chain (Ii) associated with the major histocompatibility complex (MHC) class II molecule has been shown to inhibit the mammalian lysosomal cysteine proteinase, cathepsin L, and to be a novel cysteine proteinase inhibitor, distinct from cystatins. Here we report that this same fragment also binds to and inhibits cruzipain, the cathepsin L-like enzyme from the protozoan parasite Trypanosoma cruzi. The binding of the Ii fragment to cruzipain is fast (k(ass) = 2.4 x 10(7) M(-1) s(-1) and tight (Ki = 5.8 x 10(-11) M). The inhibition is competitive. These results suggest the possibility of using the invariant chain as a model for the specific inhibition of cruzipain in vivo, i.e. as a potential drug to combat Chagas' disease.
- Subjects :
- Alternative Splicing
Animals
Antigens, Differentiation, B-Lymphocyte genetics
Histocompatibility Antigens Class II genetics
Kinetics
Peptide Fragments pharmacology
Protozoan Proteins
Antigens, Differentiation, B-Lymphocyte pharmacology
Cysteine Endopeptidases metabolism
Cysteine Proteinase Inhibitors pharmacology
Histocompatibility Antigens Class II pharmacology
Trypanosoma cruzi enzymology
Subjects
Details
- Language :
- English
- ISSN :
- 0014-5793
- Volume :
- 401
- Issue :
- 2-3
- Database :
- MEDLINE
- Journal :
- FEBS letters
- Publication Type :
- Academic Journal
- Accession number :
- 9013899
- Full Text :
- https://doi.org/10.1016/s0014-5793(96)01443-3